These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31101386)

  • 1. Corrigendum to "Protective effects of higenamine combined with [6]-gingerol against doxorubicin-induced mitochondrial dysfunction and toxicity in H9c2 cells and potential mechanisms" [Biomed. Pharmacother. 115 (2019) 108881].
    Wen J; Wang J; Li P; Wang R; Wang J; Zhou X; Zhang L; Li H; Wei S; Cai H; Zhao Y
    Biomed Pharmacother; 2019 Jul; 115():108936. PubMed ID: 31101386
    [No Abstract]   [Full Text] [Related]  

  • 2. Higenamine Combined with [6]-Gingerol Suppresses Doxorubicin-Triggered Oxidative Stress and Apoptosis in Cardiomyocytes via Upregulation of PI3K/Akt Pathway.
    Chen YL; Zhuang XD; Xu ZW; Lu LH; Guo HL; Wu WK; Liao XX
    Evid Based Complement Alternat Med; 2013; 2013():970490. PubMed ID: 23861719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum to "Dexmedetomidine protects H9C2 against hypoxia/reoxygenation injury through miR-208b-3p/Med13/Wnt signaling pathway axis" [Biomed. Pharmacother. 125 (2020) 110001].
    Wang Z; Yang Y; Xiong W; Zhou R; Song N; Liu L; Qian J
    Biomed Pharmacother; 2020 Oct; 130():110841. PubMed ID: 33032881
    [No Abstract]   [Full Text] [Related]  

  • 4. Gingerol Synergizes the Cytotoxic Effects of Doxorubicin against Liver Cancer Cells and Protects from Its Vascular Toxicity.
    Al-Abbasi FA; Alghamdi EA; Baghdadi MA; Alamoudi AJ; El-Halawany AM; El-Bassossy HM; Aseeri AH; Al-Abd AM
    Molecules; 2016 Jul; 21(7):. PubMed ID: 27399668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corrigendum to "Chlorogenic acid attenuates glucotoxicity in H9c2 cells via inhibition of glycation and PKC α upregulation and safeguarding innate antioxidant status" [Biomed. Pharmacother. 100 (2018) 467-477].
    M R PR; Nair A; Mohan S; K G R
    Biomed Pharmacother; 2021 Jan; 133():111071. PubMed ID: 33298336
    [No Abstract]   [Full Text] [Related]  

  • 6. Corrigendum to "Protective effect of dioscin against thioacetamide-induced acute liver injury via FXR/AMPK signaling pathway in vivo" [Biomed. Pharmacother. 97 (2018) 481-488].
    Zheng L; Yin L; Xu L; Qi Y; Li H; Youwei X; Han X; Liu K; Peng J
    Biomed Pharmacother; 2019 Dec; 120():109448. PubMed ID: 31615697
    [No Abstract]   [Full Text] [Related]  

  • 7. Corrigendum to "Incretin hormones receptor signaling plays the key role in antidiabetic potential of PTY-2 against STZ-induced pancreatitis" [Biomed. Pharmacother. 97 (330-338) 330-338].
    Srivastava S; Shree P; Pandey H; Tripathi YB
    Biomed Pharmacother; 2018 Nov; 107():1795. PubMed ID: 30115498
    [No Abstract]   [Full Text] [Related]  

  • 8. Corrigendum to 'dyslipidemia induced inflammatory status, platelet activation and endothelial dysfunction in rabbits: Protective role of 10-dehydrogingerdione' [Biomed. Pharmacother. (2019) pp. 456-464].
    El-Seweidy MM; Amin RS; Atteia HH; El-Zeiky RR; Al-Gabri NA
    Biomed Pharmacother; 2023 May; 161():114563. PubMed ID: 36933954
    [No Abstract]   [Full Text] [Related]  

  • 9. Stimulating basal mitochondrial respiration decreases doxorubicin apoptotic signaling in H9c2 cardiomyoblasts.
    Deus CM; Zehowski C; Nordgren K; Wallace KB; Skildum A; Oliveira PJ
    Toxicology; 2015 Aug; 334():1-11. PubMed ID: 25997894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corrigendum to "Cryptotanshinone induces melanoma cancer cells apoptosis via ROS-mitochondrial apoptotic pathway and impairs cell migration and invasion" [Biomed. Pharmacother. 82 (2016) 319-326].
    Ye T; Zhu S; Zhu Y; Feng Q; He B; Xiong Y; Zhao L; Zhang Y; Yu L; Yang L
    Biomed Pharmacother; 2019 Dec; 120():109510. PubMed ID: 31635901
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to "GJ-4 alleviates Aβ
    Zhang Z; Liu H; Zhao Z; Zang C; Ju C; Li F; Wang L; Yang H; Bao X; Yu Y; Yao X; Zhang D
    Biomed Pharmacother; 2020 Aug; 128():110335. PubMed ID: 32505384
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to "Evaluation of antiviral effect and toxicity of total flavonoids extracted from Robinia pseudoacacia cv. idaho" [Biomed. Pharmacother. 118 (2019) 109335].
    Guo H; Wan X; Niu F; Sun J; Shi C; Ye JM; Zhou C
    Biomed Pharmacother; 2020 Mar; 123():109809. PubMed ID: 31917053
    [No Abstract]   [Full Text] [Related]  

  • 13. Corrigendum to "Herb-drug interaction: A case study of effects and involved mechanisms of cisplatin on the pharmacokinetics of ginsenoside Rb1 in tumor-bearing mice" [Biomed. Pharmacother. 110 (2019) 95-104].
    Zhou J; Wu J; Wu CY; Long F; Shen H; Zhang W; Li SL
    Biomed Pharmacother; 2019 Jun; 114():108827. PubMed ID: 30954310
    [No Abstract]   [Full Text] [Related]  

  • 14. Retraction notice to "miR-208b targets Bax to protect H9c2 cells against hypoxia-induced apoptosis" [Biomed. Pharmacother. 106 (2018) 1751-1759].
    Zhou YL; Sun Q; Zhang L; Li R
    Biomed Pharmacother; 2022 Apr; 148():112714. PubMed ID: 35164994
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to "Dexmedetomidine relieves formaldehyde-induced pain in rats through both α2 adrenoceptor and imidazoline receptor" [Biomed. Pharmacother. 90 (2017) 914-920].
    Zhang H; Yan X; Wang DG; Leng YF; Wan ZH; Liu YQ; Zhang Y
    Biomed Pharmacother; 2017 Dec; 96():1569. PubMed ID: 29153378
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to "MiR-23a-3p acts as an oncogene and potential prognostic biomarker by targeting PNRC2 in RCC" [Biomed. Pharmacother. 110 (2019) 656-666].
    Quan J; Pan X; Li Y; Hu Y; Tao L; Li Z; Zhao L; Wang J; Li H; Lai Y; Zhou L; Lin C; Gui Y; Ye J; Zhang F; Lai Y
    Biomed Pharmacother; 2019 Apr; 112():108755. PubMed ID: 30871752
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to "Pro-apoptotic effects of Amblyomin-X in murine renal cell carcinoma "in vitro" [Biomed. Pharmacother. 66 (2012) 64-69].
    Akagi EM; de Sá Júnior PL; Simons SM; Bellini MH; Barreto SA; Chudzinski-Tavassi AM
    Biomed Pharmacother; 2019 Oct; 118():109108. PubMed ID: 31235339
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to "double sword role of EZH2 in leukemia" [Biomed. Pharmacother. 98 (2018) 626-635].
    Safaei S; Baradaran B; Hagh MF; Alivand MR; Talebi M; Gharibi T; Solali S
    Biomed Pharmacother; 2018 May; 101():786. PubMed ID: 29525673
    [No Abstract]   [Full Text] [Related]  

  • 19. Corrigendum to "Luteolin, a flavonoid, as an anticancer agent: A review" [Biomed. Pharmacother. 112 (2019) 108612].
    Imran M; Rauf A; Abu-Izneid T; Nadeem M; Shariati MA; Khan IA; Imran A; Erdogan Orhan I; Rizwan M; Atif M; Aslam Gondal T; Mubarak MS
    Biomed Pharmacother; 2019 Aug; 116():109084. PubMed ID: 31178263
    [No Abstract]   [Full Text] [Related]  

  • 20. Corrigendum to "Comparative study of therapeutic response to baclofen vs tolperisone in spasticity" [Biomed. Pharmacother. 87 (2017) 628-635].
    Agarwal S; Patel T; Shah N; Patel BM
    Biomed Pharmacother; 2017 Aug; 92():1140. PubMed ID: 28623068
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.